170 related articles for article (PubMed ID: 11960890)
1. Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2.
Sperfeld AD; Hein C; Schröder JM; Ludolph AC; Hanemann CO
Brain; 2002 May; 125(Pt 5):996-1004. PubMed ID: 11960890
[TBL] [Abstract][Full Text] [Related]
2. Polyneuropathy in neurofibromatosis 2: clinical findings, molecular genetics and neuropathological alterations in sural nerve biopsy specimens.
Hagel C; Lindenau M; Lamszus K; Kluwe L; Stavrou D; Mautner VF
Acta Neuropathol; 2002 Aug; 104(2):179-87. PubMed ID: 12111361
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis 2 with peripheral neuropathies: Electrophysiological, pathological and genetic studies of a Taiwanese family.
Kuo HC; Chen SR; Jung SM; Wu Chou YH; Huang CC; Chuang WL; Wei KC; Ro LS
Neuropathology; 2010 Oct; 30(5):515-23. PubMed ID: 20113402
[TBL] [Abstract][Full Text] [Related]
4. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies.
Ruggieri M; Praticò AD; Serra A; Maiolino L; Cocuzza S; Di Mauro P; Licciardello L; Milone P; Privitera G; Belfiore G; Di Pietro M; Di Raimondo F; Romano A; Chiarenza A; Muglia M; Polizzi A; Evans DG
Acta Otorhinolaryngol Ital; 2016 Oct; 36(5):345-367. PubMed ID: 27958595
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
Sirén V; Antinheimo JP; Jääskeläinen J; Böhling T; Carpén O; Vaheri A
Acta Neurochir (Wien); 2004 Feb; 146(2):111-8. PubMed ID: 14963743
[TBL] [Abstract][Full Text] [Related]
6. Mononeuropathy multiplex as the initial manifestation of neurofibromatosis type 2.
Gijtenbeek JM; Gabreëls-Festen AA; Lammens M; Zwarts MJ; van Engelen BG
Neurology; 2001 Jun; 56(12):1766-8. PubMed ID: 11425952
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, Management, and New Therapeutic Options in Childhood Neurofibromatosis Type 2 and Related Forms.
Ruggieri M; Praticò AD; Evans DG
Semin Pediatr Neurol; 2015 Dec; 22(4):240-58. PubMed ID: 26706012
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromatosis type 2.
Evans DG; Sainio M; Baser ME
J Med Genet; 2000 Dec; 37(12):897-904. PubMed ID: 11106352
[TBL] [Abstract][Full Text] [Related]
9. [Neurofibromatosis type 2].
Goutagny S; Bouccara D; Bozorg-Grayeli A; Sterkers O; Kalamarides M
Rev Neurol (Paris); 2007 Sep; 163(8-9):765-77. PubMed ID: 17878803
[TBL] [Abstract][Full Text] [Related]
10. Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients.
Ruggieri M; Iannetti P; Polizzi A; La Mantia I; Spalice A; Giliberto O; Platania N; Gabriele AL; Albanese V; Pavone L
Neuropediatrics; 2005 Feb; 36(1):21-34. PubMed ID: 15776319
[TBL] [Abstract][Full Text] [Related]
11. Schwann cell proliferation as the cause of peripheral neuropathy in neurofibromatosis-2.
Iwata A; Kunimoto M; Inoue K
J Neurol Sci; 1998 Apr; 156(2):201-4. PubMed ID: 9588858
[TBL] [Abstract][Full Text] [Related]
12. Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathy.
Schulz A; Baader SL; Niwa-Kawakita M; Jung MJ; Bauer R; Garcia C; Zoch A; Schacke S; Hagel C; Mautner VF; Hanemann CO; Dun XP; Parkinson DB; Weis J; Schröder JM; Gutmann DH; Giovannini M; Morrison H
Nat Neurosci; 2013 Apr; 16(4):426-33. PubMed ID: 23455610
[TBL] [Abstract][Full Text] [Related]
13. An update on the CNS manifestations of neurofibromatosis type 2.
Coy S; Rashid R; Stemmer-Rachamimov A; Santagata S
Acta Neuropathol; 2020 Apr; 139(4):643-665. PubMed ID: 31161239
[TBL] [Abstract][Full Text] [Related]
14. An unusual clinical course of peripheral neuropathy in neurofibromatosis type 2.
Kuo HC; Chu CC; Jung SM; Huang CC
J Clin Neuromuscul Dis; 2004 Jun; 5(4):195-201. PubMed ID: 19078742
[TBL] [Abstract][Full Text] [Related]
15. Focal amyotrophy in neurofibromatosis 2.
Trivedi R; Byrne J; Huson SM; Donaghy M
J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):257-61. PubMed ID: 10896706
[TBL] [Abstract][Full Text] [Related]
16. The neurofibromatosis type 2 gene is inactivated in schwannomas.
Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
[TBL] [Abstract][Full Text] [Related]
17. Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).
Ferner RE; Hughes RA; Hall SM; Upadhyaya M; Johnson MR
J Med Genet; 2004 Nov; 41(11):837-41. PubMed ID: 15520408
[TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis type 2.
Evans DG
Handb Clin Neurol; 2015; 132():87-96. PubMed ID: 26564072
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes of peripheral nerve schwannoma excision in neurofibromatosis type 2 patients and non-neurofibromatosis type 2 patients: A case control study.
Bendon CL; Furniss D; Giele HP
J Plast Reconstr Aesthet Surg; 2015 Sep; 68(9):1199-203. PubMed ID: 26139580
[TBL] [Abstract][Full Text] [Related]
20. Surgical Management of Peripheral Nerve Pathology in Patients With Neurofibromatosis Type 2.
Peyre M; Tran S; Parfait B; Bernat I; Bielle F; Kalamarides M
Neurosurgery; 2023 Feb; 92(2):317-328. PubMed ID: 36637268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
